The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALECTOR INC COM 014442107   5,531,322 3,545,719 SH   DFND   0 3,545,719 0
CARISMA THERAPEUTICS INC COM 14216R101   63,349 1,473,240 SH   DFND   0 1,473,240 0
ENTRADA THERAPEUTICS INC COM 29384C908   17,884,815 1,739,768 SH   DFND   0 1,739,768 0
EVAXION BIOTECH A/S SPONSORED ADS 29970R204   5,791,381 1,214,126 SH   DFND   0 1,214,126 0
KYMERA THERAPEUTICS INC COM 501575104   60,082,159 772,165 SH   DFND   0 772,165 0
MODERNA INC COM 60770K107   68,068,523 2,308,190 SH   DFND 1 0 2,308,190 0
NEUPHORIA THERAPEUTICS INC COM 64136E102   38,905 10,027 SH   DFND 1 0 10,027 0
PERSONALIS INC COM 71535D106   111,797,746 14,044,943 SH   DFND 1 0 14,044,943 0
SUTRO BIOPHARMA INC COM 869367102   3,151,101 272,351 SH   DFND 1 0 272,351 0
TUHURA BIOSCIENCES COM 898920103   10,556 13,950 SH   DFND 1 0 13,950 0
VIRIDIAN THERAPEUTICS INC COM 92790C104   2,907,044 93,414 SH   DFND   0 93,414 0
XILIO THERAPEUTICS INC COM 98422T100   949,902 1,483,758 SH   DFND   0 1,483,758 0